A disruptive technology to tackle brain cancer and glioblastoma
News
Hemerion is accelerating its international expansion with the granting of new patents in the United States and Japan
In late July 2026, Hemerion was notified of the granting of new patents in two major healthcare markets: the United States and Japan. This international expansion strengthens Hemerion’s intellectual property… ...
Hemerion Research Grant: Two International Awards Presented and a New Edition Announced
To broaden the scope of its research, Hemerion funds initiatives and projects led by scientists or clinical teams capable of offering new perspectives on concrete challenges in the fight against… ...
American Association of Neurological Surgeons (AANS) Annual Meeting: Hemerion Gains Momentum in the U.S.
Hemerion’s participation in the American Association of Neurological Surgeons (AANS) Annual Meeting from May 1 to 4, 2026, allowed our team to strengthen ties with international clinicians and showcase its… ...
Stay tuned to our clinical advances
They talk about us
